| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1023937946 |
| P356 | DOI | 10.1038/SJ.CGT.7700392 |
| P698 | PubMed publication ID | 11781658 |
| P5875 | ResearchGate publication ID | 11575930 |
| P2093 | author name string | Rommelaere J | |
| Cornelis JJ | |||
| Noteborn MH | |||
| Dinsart C | |||
| Dege AY | |||
| Olijslagers S | |||
| Voorhoeve M | |||
| P2860 | cites work | A new technique for the assay of infectivity of human adenovirus 5 DNA | Q27860797 |
| BCL-2 stimulates Apoptin-induced apoptosis. | Q33740326 | ||
| Induction of programmed cell death by parvovirus H-1 in U937 cells: connection with the tumor necrosis factor alpha signalling pathway | Q33785311 | ||
| Autonomous parvoviruses as gene transfer vehicles | Q34002345 | ||
| Apoptin induces apoptosis in human transformed and malignant cells but not in normal cells | Q36159888 | ||
| A model for tumor suppression using H-1 parvovirus | Q36547966 | ||
| Adenoviral-mediated gene transfer in lymphocytes. | Q36641367 | ||
| Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus | Q36697316 | ||
| Antineoplasic activity of parvoviruses | Q36935786 | ||
| Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors | Q40808752 | ||
| Highly efficient transduction and expression of cytokine genes in human tumor cells by means of autonomous parvovirus vectors; generation of antitumor responses in recipient mice | Q40892978 | ||
| cis requirements for the efficient production of recombinant DNA vectors based on autonomous parvoviruses. | Q40938736 | ||
| BAG-1 inhibits p53-induced but not apoptin-induced apoptosis | Q41135526 | ||
| Cooperation of oncogenes in cell transformation and sensitization to killing by the parvovirus minute virus of mice | Q41609392 | ||
| Replication of minute virus of mice DNA in adenovirus-infected or adenovirus-transformed cells | Q41732924 | ||
| Specific tumor-cell killing with adenovirus vectors containing the apoptin gene | Q43668971 | ||
| Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts | Q44831966 | ||
| Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response | Q45760767 | ||
| Comparative evaluation of several DNA binding dyes in the detection of apoptosis-associated chromatin degradation by flow cytometry | Q54167572 | ||
| Parvovirus H-1 inhibits growth of short-term tumor-derived but not normal mammary tissue cultures | Q70498436 | ||
| Induction of apoptosis in vitro and in vivo by H-1 parvovirus infection | Q77764302 | ||
| P433 | issue | 12 | |
| P921 | main subject | oncolytic virus | Q1560099 |
| P304 | page(s) | 958-965 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Cancer Gene Therapy | Q15763088 |
| P1476 | title | Potentiation of a recombinant oncolytic parvovirus by expression of Apoptin | |
| P478 | volume | 8 |
| Q34059205 | Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1. |
| Q39686372 | Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production |
| Q40180003 | Additive cytotoxic effect of apoptin and chemotherapeutic agents paclitaxel and etoposide on human tumour cells |
| Q39350562 | Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitment |
| Q97526737 | Apoptin as a Tumor-Specific Therapeutic Agent: Current Perspective on Mechanism of Action and Delivery Systems |
| Q39484906 | Apoptin enhances the oncolytic properties of Newcastle disease virus |
| Q34987167 | Autonomous parvovirus vectors |
| Q33737706 | B1 lymphocytes and myeloid dendritic cells in lymphoid organs are preferential extratumoral sites of parvovirus minute virus of mice prototype strain expression |
| Q39732500 | Chimeric and pseudotyped parvoviruses minimize the contamination of recombinant stocks with replication-competent viruses and identify a DNA sequence that restricts parvovirus H-1 in mouse cells |
| Q34226663 | Chromosomal integration and homologous gene targeting by replication-incompetent vectors based on the autonomous parvovirus minute virus of mice |
| Q36401504 | Gene therapy for gastric cancer: is it promising? |
| Q92879061 | H-1 Parvovirus as a Cancer-Killing Agent: Past, Present, and Future |
| Q53876306 | Investigation of the sensitivities of distinct gastric cancer cells to parvovirus H-1 induced cytotoxicity. |
| Q37959247 | Mechanisms of Apoptin-induced cell death |
| Q39814060 | Novel adenovirus-based helper system to support production of recombinant parvovirus |
| Q36769180 | Oncolytic viruses in cancer therapy |
| Q33638956 | Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo |
| Q47242457 | Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro. |
| Q35912403 | Replication-selective oncolytic viruses in the treatment of cancer. |
| Q27676651 | Structural Characterization of H-1 Parvovirus: Comparison of Infectious Virions to Empty Capsids |
| Q35848667 | Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma |
| Q37028023 | Trial watch: Oncolytic viruses for cancer therapy |
| Q38269469 | Viral genes as oncolytic agents for cancer therapy |
| Q38253646 | Virotherapy in cancer |
| Q35053353 | λ Phage nanobioparticle expressing apoptin efficiently suppress human breast carcinoma tumor growth in vivo |
Search more.